Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
about
Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALSCurrent Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisAlbumin and multiple sclerosisBreaking boundaries-coagulation and fibrinolysis at the neurovascular interfaceRedox control of microglial function: molecular mechanisms and functional significanceThe blood-brain barrier in cortical multiple sclerosis lesionsReduction of circulating endothelial cells in peripheral blood of ALS patientsDiffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.Advanced MRI and staging of multiple sclerosis lesionsHypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosisImportance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.Weekly multimodal MRI follow-up of two multiple sclerosis active lesions presenting a transient decrease in ADC.Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.Fibrinogen inhibits neurite outgrowth via beta 3 integrin-mediated phosphorylation of the EGF receptorBlood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentationSphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier.The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.A potential role for CD8+ T-cells as regulators of CNS vascular permeability.Neurovascular and Immuno-Imaging: From Mechanisms to Therapies. Proceedings of the Inaugural Symposium.Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosisAbnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRICellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging.Partial recovery of the damaged rat blood-brain barrier is mediated by adherens junction complexes, extracellular matrix remodeling and macrophage infiltration following focal astrocyte loss.Vascular damage in the central nervous system: a multifaceted role for vascular-derived TGF-β.Fibrinogen as a key regulator of inflammation in disease.Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances.Microglia-blood vessel interactions: a double-edged sword in brain pathologies.Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.CD169 is a marker for highly pathogenic phagocytes in multiple sclerosis.Brain endothelial barrier passage by monocytes is controlled by the endothelin system.Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.Enlarged perivascular spaces are associated with the disease activity in systemic lupus erythematosusPerivascular spaces--MRI marker of inflammatory activity in the brain?Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells.Multiple sclerosis and the blood-central nervous system barrier.Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study.Significance of Virchow-Robin spaces in patients newly diagnosed with multiple sclerosis: a case-control study in an Arab population.
P2860
Q21144409-ACC1C425-29AA-446C-8E1C-530EFD8F451EQ26740330-84D17D5A-F99B-45A5-AFA8-19CF299293B7Q26749307-0A19CD82-6A38-4BA2-84FA-E393D673A935Q26781646-C28BC29F-303F-4370-88FC-70BB76FFB665Q27000279-9A2FFAEB-E9A3-4C3F-8895-C5F84DDDF2B9Q28296839-10754D92-8C24-45AB-AB67-7062EF5F26C7Q28752226-5CAAB694-3F77-49AA-A5F9-4B08AD9FD96DQ30581773-233E5871-6EC3-4B66-A8AD-AAF04CBCE54EQ30825494-588574E4-A2A0-4DCA-8B69-4AF2ED393F2AQ33735371-551F0F33-08BE-4E62-892D-1D1323BDDC92Q33740931-54F468FB-CB61-4504-93A8-2E124D2DD23DQ34476372-65CE6E77-2A1C-41CA-A60C-5EB01BED05CBQ35024646-576EA04D-4590-4DB5-B44E-E01110E67D61Q35620086-D38052DB-F01D-4C3B-96EB-128837CEFB4FQ35880183-F6D79A90-30FD-457A-9470-04CBDC1FB6F1Q36084774-5AE9BB88-700E-44E5-9BA2-85A72FEDF85FQ36181772-BF35D8C5-C087-4B3C-900F-BE9FD7A6D174Q36267176-A23C93C7-8F16-4A15-B3B5-9F2AAE08E4DBQ36445604-881A4CAD-5855-4348-A4E4-E886F59A3056Q36474325-EA193939-DD0B-4AA1-BA45-A4B8052F69F1Q36602139-DF4CB48C-1C52-4BE1-983C-6BE528DFB4DCQ36618676-0A3FC568-CF18-46B7-8C57-C818AD079E99Q37414011-68091CA2-0C42-4E92-90AA-709E28859CB1Q37540582-A063FB3D-1925-44C8-9DD5-CC69997F8151Q37668307-4A73B53F-6D1C-45CD-99F9-B872F8A0A2FCQ37727943-0C9BBDAE-291E-456C-A784-82D05C3339B7Q37919387-C53D0150-8D0C-459E-9089-074ADE1CC750Q37950860-C1A3298C-6C8B-47B4-A714-4529CB500512Q38017702-521F9B8C-4C3D-48CD-8C42-40F933063271Q38681675-8FD1FC40-C8D6-4C36-9D72-9C49E28487B1Q38744509-443AD3B4-57D2-4954-8DB3-B6FE4E68B2D4Q38918340-348ACF71-1DC2-4959-8ED7-AF3E6C52E16CQ39503256-E1E07FC2-B1A2-41E2-92D5-EB84D2AC6CA6Q40358564-4D1363FA-38F1-4015-8599-AD5A9B7B81C4Q42282494-C32E0462-8697-4E0C-A5B8-F7D7191FD8AEQ42439736-AA0656AA-20C3-45C7-B3FA-BD2C49E1C34FQ42499339-32A3E2AA-3ADB-43B8-AB2B-A61676FECB16Q43136157-B933B107-778F-4D3D-9E7B-37916AA48262Q43516664-F32A13C3-E024-44D6-A8E2-CFAF83311DF6Q45959674-9E9E0D99-C1D3-41F0-81A8-66362BA38E0D
P2860
Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Blood-brain barrier alteration ...... tem MRI in multiple sclerosis.
@ast
Blood-brain barrier alteration ...... tem MRI in multiple sclerosis.
@en
Blood-brain barrier alteration ...... tem MRI in multiple sclerosis.
@nl
type
label
Blood-brain barrier alteration ...... tem MRI in multiple sclerosis.
@ast
Blood-brain barrier alteration ...... tem MRI in multiple sclerosis.
@en
Blood-brain barrier alteration ...... tem MRI in multiple sclerosis.
@nl
prefLabel
Blood-brain barrier alteration ...... tem MRI in multiple sclerosis.
@ast
Blood-brain barrier alteration ...... tem MRI in multiple sclerosis.
@en
Blood-brain barrier alteration ...... tem MRI in multiple sclerosis.
@nl
P2093
P1476
Blood-brain barrier alteration ...... tem MRI in multiple sclerosis.
@en
P2093
Catharina M P Vos
Elise S van Haastert
Jeroen J G Geurts
Lisette Montagne
Paul van der Valk
P304
P356
10.1016/J.NBD.2005.06.012
P577
2005-07-21T00:00:00Z